rs2071093

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000539.3(RHO):​c.*43C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0855 in 1,333,446 control chromosomes in the GnomAD database, including 5,324 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 512 hom., cov: 32)
Exomes 𝑓: 0.086 ( 4812 hom. )

Consequence

RHO
NM_000539.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.175

Publications

6 publications found
Variant links:
Genes affected
RHO (HGNC:10012): (rhodopsin) The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]
RHO Gene-Disease associations (from GenCC):
  • congenital stationary night blindness autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 4
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fundus albipunctatus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 3-129533761-C-A is Benign according to our data. Variant chr3-129533761-C-A is described in ClinVar as Benign. ClinVar VariationId is 256382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHONM_000539.3 linkc.*43C>A 3_prime_UTR_variant Exon 5 of 5 ENST00000296271.4 NP_000530.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOENST00000296271.4 linkc.*43C>A 3_prime_UTR_variant Exon 5 of 5 1 NM_000539.3 ENSP00000296271.3

Frequencies

GnomAD3 genomes
AF:
0.0775
AC:
11786
AN:
152130
Hom.:
511
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0686
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0770
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.0631
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.0382
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0839
Gnomad OTH
AF:
0.0951
GnomAD2 exomes
AF:
0.0813
AC:
20150
AN:
247754
AF XY:
0.0854
show subpopulations
Gnomad AFR exome
AF:
0.0709
Gnomad AMR exome
AF:
0.0562
Gnomad ASJ exome
AF:
0.163
Gnomad EAS exome
AF:
0.0632
Gnomad FIN exome
AF:
0.0367
Gnomad NFE exome
AF:
0.0842
Gnomad OTH exome
AF:
0.0997
GnomAD4 exome
AF:
0.0865
AC:
102165
AN:
1181198
Hom.:
4812
Cov.:
17
AF XY:
0.0885
AC XY:
53245
AN XY:
601450
show subpopulations
African (AFR)
AF:
0.0701
AC:
1962
AN:
27980
American (AMR)
AF:
0.0582
AC:
2583
AN:
44346
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
4024
AN:
24512
East Asian (EAS)
AF:
0.0491
AC:
1883
AN:
38340
South Asian (SAS)
AF:
0.118
AC:
9519
AN:
80704
European-Finnish (FIN)
AF:
0.0382
AC:
1977
AN:
51736
Middle Eastern (MID)
AF:
0.130
AC:
661
AN:
5074
European-Non Finnish (NFE)
AF:
0.0871
AC:
74714
AN:
857312
Other (OTH)
AF:
0.0946
AC:
4842
AN:
51194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5156
10312
15467
20623
25779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2532
5064
7596
10128
12660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0775
AC:
11800
AN:
152248
Hom.:
512
Cov.:
32
AF XY:
0.0771
AC XY:
5738
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0687
AC:
2856
AN:
41544
American (AMR)
AF:
0.0769
AC:
1176
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
558
AN:
3468
East Asian (EAS)
AF:
0.0627
AC:
325
AN:
5182
South Asian (SAS)
AF:
0.107
AC:
516
AN:
4822
European-Finnish (FIN)
AF:
0.0382
AC:
405
AN:
10616
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0839
AC:
5706
AN:
68002
Other (OTH)
AF:
0.0960
AC:
203
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
543
1086
1628
2171
2714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0701
Hom.:
223
Bravo
AF:
0.0797
Asia WGS
AF:
0.106
AC:
371
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pigmentary retinal dystrophy Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 4 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital stationary night blindness autosomal dominant 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
3.0
DANN
Benign
0.68
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071093; hg19: chr3-129252604; API